We quantified the total variability (reproducibility) and the within-patient but between repeat anaes thetics variability (repeatability) in measures which are used to judge the predictive performance of our physiological model. We studied 14 patients who received enflurane closed-circuit anaesthesia on two occasions. The end-tidal concentrations measured and those predicted served to calculate the predictive performance measures of the model: root mean squared error (rmse=total error), bias (systematic error) and scatter (error around the bias). The overall results were: rmse 15 (7) %, bias 0(14)% and scatter 9 (3) % (grand mean (total sd)). The within-patient sd values were smaller for the rmse (4%) and bias (10%), but not for scatter (3%). The repeat rmse values and biases were linked to the first results. This implies that these performance measures depended partly on the patient. As there was no association between the personal performance measures and age, sex, body weight, body surface area or body mass index, these characteristics cannot be used to further tune the model. (Br. J. Anaesth. 1997; 79: 488-496). patient to predict the concentrations of a drug, variability in pharmacokinetic responses must be J u A i taken into account. Until now our clinical studies have provided information only on the betweenpatient variability, expressed in terms of variability in the predictive performance measures of the model, because different patients were studied only once. A major unresolved issue was the repeatability of the performance measures of the model in a patient presenting for repeated anaesthetic procedures. Therefore, we studied patients who underwent enflurane closed-circuit anaesthesia twice. The objectives were: to evaluate the extent of correspon dence between the predictive performance measures of the model obtained in the same patient on two occasions under similar clinical conditions; to deter mine if these measures varied more among than within patients; and to assess the association of the performance measures of the model with patient characteristics.
Using average values of physiological variables and physicochemical data, we have defined a physio logical model for closed-circuit inhalation anaes thesia.1 It is capable of predicting end-expired concentrations after injection of a liquid anaesthetic into a closed-circuit breathing system. Previously we have evaluated the predictive performance of the model by examining the differences between the concentrations predicted and those measured in surgical patients. The observed prediction errors were condensed, per patient, into single performance measures. These identify the total error size (rmse), systematic error (bias) and error around the bias (scatter). Close agreement predictions and measurements was found in groups of patients anaesthetized with different volatile anaesthetics. 24 Yet, if we wish to apply a model in a particular PATIENTS AND ANAESTHETIC MANAGEMENT we a validation study of our system model enflurane -circuit anaes thesia in 50 patients. They underwent elective eye surgical procedures, and 15 needed a second surgical intervention of the same type. After approval of the Institutional Ethics and Research Committee, these 15 consenting, Caucasian patients (ASA I or II) were enrolled in the study.
First anaesthetic procedure
Diazepam 5-10 mg and droperidol 2.5-5 mg were given orally 1 h before surgery. Anaesthesia was M M VMM m » a « M ( » i i i | i » ' i n W i ) n » » n « W M » 489 induced with fentanyl 0.1-0.2 mg i.v. and a dose of thiopentone sufficient to abolish the eyelash reflex. Thereafter, vecuronium 0.1 mg kg'1 i.v. was admin istered. After placement of a cuffed tracheal tube, the lungs of the patients were ventilated artificially with a high fresh gas flow of oxygen and nitrous oxide in a 1:2 ratio until the end-tidal nitrogen con centration was less than 1 vol% or for a maximum of 5 min. Subsequently, the anaesthetic system was closed and closed-circuit anaesthesia commenced. The fresh gas flow of oxygen and nitrous oxide was adjusted manually to maintain the inspired oxygen concentration at 30-40 vol%. The end-tidal carbon dioxide concentration was 4.0-5.0 vol%. Enflurane anaesthesia was administered using the liquid injection method by the same (P. M. V.). Boluses of liquid enflurane were injected into the expiratory limb of the system: one of 0.02 ml kg 1 (±0.1 ml) after the start of closed-circuit condi tions and repeated increments of 0.01 ml k g 1 during maintenance. We did not use a rigid drug regimen, but modified enflurane administration to provide adequate anaesthesia as in good clinical practice. Therefore, we monitored carefully the patient's response to surgery by assessment of non-invasive arterial pressure measurement, heart rate and heart rate variability judged by ear with the aid of pulse oximetry, and also end-tidal enflurane concentra tion. Additional i.v. fentanyl 0.05-0.1 mg was given according to clinical needs. This was separated from the first by at least 2 weeks. Patients received the same premedication. Anaesthesia was induced the fresh gas flow in order to provide closed-circuit conditions mostly necessitated frequent adjustments of tidal volume and the flowmeters at the beginning of closed-circuit anaesthesia. Five minutes were required until we were confident that tidal volume was equal during repeated measurements. There fore, we only analysed data acquired after this initial non state A respiratory mass spectrometer (Centronic 200 MGA or QP9000; CaSE, continuously sampled mam. at the Y-piece of the via a am port (the sample flow is part of the model) variation of the mass readings was 2%. Before starting each measurement we verified calibration of the mass spectrometer for enflurane with a calibration gas mixture containing 1% enflurane in 30% oxygen, 30% nitrous oxide and balance gas nitrogen (AGA Gas, Amsterdam, The Netherlands). A personal computer system with a 12-bit analogue-to-digital board (Keithley Metrabyte, Taunton, MA, USA) processed the signals from the mass spectrometer. The data acquisition software was developed with the aid of ASYST (Keithley Metrabyte). On-line analysis of the respiratory waveforms allowed continuous monitoring in the operating room of the actual inspired and endexpired concentrations of nitrogen, oxygen, carbon dioxide, nitrous oxide, argon and enflurane. The trends of the inspired and end-expired concentra tions of enflurane and oxygen of the last 20 min were The last end for each 10-s concentration for further data as The same parameters for mechanical ventilation (fre quency, tidal volume) were used. By design we did not aim to replicate the timetable of enflurane injections from the first anaesthetic. As in the first anaesthetic procedure, individual's anaesthetic needs under given surgical conditions prevailed as necessary.
For both procedures, we noted the times and volumes of liauid enflurane, and total enflurane concentration (vol%).
, we E uv-To evaluate our an expressed the average measured end-tidal and nitrous oxide concentrations as MAC corrected for age (mMAC) and their sum (i.e. total mMAC).5 Before evaluating anaesthetic requirements and calculating of prediction, we curtailed one of the two per patient, that is the one with the longest Thus we considered only repeated observations exactly the same duration. Table 1 summarizes the measures which serve to determine the predictive performance of our model. The prediction error (pe) is the difference between a predicted and measured value of enflurane concen tration, expressed as a percentage of the measured value: pe and squared prediction error (pe2) are calculated for each time period of 10 s. These two quantities are used to provide the following three predictive performance measures.
(1) Root mean squared error (rmse). The mean squared error (mse) is the average of the squared prediction errors. Rmse is defined as v/mse and is a measure of the total error budget for an individual patient during one anaesthetic procedure. It is not influenced by the sign of the prediction errors and can be formulated as being composed of bias and scatter (table 1).
(
2) Bias, that is the of the prediction errors for an individual patient, is a measure of the systematic component of error. It can be either positive or negative, thus indicating over prediction or under predictions (3) Scatter is a measure of the variation of the prediction errors around their mean (bias) during one procedure.
These three measures were calculated for the first and the repeat anaesthetic procedure. Thus per patient we had a first and repeat rmse, bias and scatter, as illustrated in figure 1. 
measurements as there is no relationship between the differences in repeated observations and averaged individual rmse values.
(2 ) Figure 3 Table 3 summarizes the key results of the variability in the three predictive performance measures. For rmse, the total variance s2T was nearly four-fold the within-patient variance ¿'2W, thus s2w was much smaller than s2 B. The ratio s d t / s d w was 1.98. For bias, 52t was twice as large as <rw , s2 w was similar to s2b , and the ratio s d t / s d w was 1.39. For scatter, 
b (left) provides the two sets of systematic errors plotted against each other. The difference between the first and repeat bias is not greater than 11% for most patients (three patients are situated out of this zone). The greatest disparity in bias between repeated observations is -15 vs

ANALYSIS OF VARIANCE
D iscu ssion
We have found that there was a link between the first and repeated measurement of the performance of the model. This was so for the measures rmse (total error size) and bias (systematic error), but not for scatter ( fig. 3 ). This finding implies that most patients behaved similarly during both anaesthetics. 
RATIONALE FOR
EXTENT OF CORRESPONDENCE
It is most unlikely that repeated observations on the same patient would give identical values for each variable (rmse, bias or scatter) in every individual. I t 3 illustrates percentage of subjects showing agreement to within selected numbers of units. We used zones around the lines of identity of approximately one-sixth of the full axis range, thus indicating differed little in comparison with the total range of variability between patients. In spite of a total range of 7-29%, the repeat rmse differed by no more than 5% from the first for 10 of 14 patients. The systematic error had a wide range ( -27% to +26 %)5 whereas the difference between the first and repeat bias was not greater than 11%> for most patients. If we translate the percentage bias into vol% of end-expired concentration, a difference of less than 11% implies that the systematic errors on the two occasions differed by less than 0.11 vol% for each vol% of anaesthetic. This is a small discrepancy in clinical terms. It appears that individuals who have or have not deviated from an anticipated pharmacological behaviour on one occasion tend to behave alike on an alternate similar occasion. Subjects can deviate, even grossly, from the grand mean, yet exhibit a high level of repeatability (obser vations in the top right and bottom left of figure 3b) (left). Therefore, model-based predictions have an extra clinical value.
COMPONENTS OF BIOLOGICAL VARIABILITY
We estimated that, although the repeat scatters differed little for most patients (fig. 3) , 90% of the total variance resulted from within-patient variance (table 3). As scatter varies much more from one anaesthetic to the next in any one patient than it does between the average scatter for different patients (fig. 3c (right) ), it may be that much of this scatter is not caused by variation within the patient but by some other cause.
We estimated for rmse and bias that 75%> and reveal if our model-based predictions can be scaled further between individuals by other "personal factors.
Our results ask the question whether we should save patient-related findings in a directly accessible "anaesthetic passport" (bearing the patient's anaesthetic finger printings). This may be an aid to anaesthetists in the future.22 They may plan the anaesthetic of their patients on the basis of the average behaviour of a standard human, perhaps also according to institutional algorithms. Subsequently they may adapt the anaesthetic drug administration to tailor the anaesthetic to the physiological status of their patient. Models can facilitate these processes of decision making. But anaesthetists are also interested in identifying those patients who are likely to deviate from anticipated average behaviour. Our results suggest that determination of bias (or rmse) in a patient on one occasion, even if that bias is large, may be a useful predictor of bias on subsequent occasions. This is well illustrated in figure 3 b (left), apart from patient No. 12. Other authors have shown that the correlation of anaesthetic uptake with easily observable patient characteristics is poor.1823 If the patient must receive another anaesthetic, the judicious use of data identified during a former anaesthetic may be the best basis available to adjust the "rules of thumb" which anaesthetists use when managing a patient. 24 
RESERVATIONS
49%, respectively, of the total variance was caused by between-patient variance. In contrast with scatter, the variance in rmse was mainly attributable to systematic differences between patients. For bias, variance was distributed evenly among its two components.
Comparing the results of this study with those of others is difficult because data on recurrent measure ments of inhaled anaesthetics are scarce and do not include estimates of both between-patient and within-patient but between repeat anaesthetic variabilities.18 20 Studies in an other area of clinical research also found that prediction within patients was easier than that between patients when using a physiologically based formula, and that such information can be useful in clinical practice.21
The data showing high repeatability were gathered under similar clinical conditions. Therefore, repeat ability values should not be extrapolated to apparently different conditions. Model-based drug regimens and algorithms are not intended as rigid recipes.18 They offer a reasonable approach to anaes thetic management that must be individualized with the aid of clinical observations and vigilant monitor ing of end-tidal concentrations and haemodynamic variables. 25 A few patients with poor consistency and one out lier were found. Their presence suggests that the use of an adaptive model or feedback-controlled anaesthesia is worth considering for future develop ment.232627 The control algorithms needed can be developed initially with the aid of a model which should be well validated and exhibit a realistic
ASSOCIATION W ITH PATIENT CHARACTERISTICS
The high within-patient consistency was a reason for investigating the possible association of individual results for rmse or bias with age, sex, body weight, BMI or BSA. As in previous studies, a relationship between individual patient characteristics and performance measures could not be established.2 4 This is not surprising because these data are primary inputs to the model. It uses an individualized input to calculate some physiological variables such as cardiac output and functional residual capacity. The characteristics studied cannot be used to improve the model. Additional, yet unknown, factors may contribute in a significant extent to an individual's pharmacokinetic response. Future research may amount of variability such as that found in the present study.
We believe that repeatability data should available to each research group studying the predic tive performance of models, not only because it is important to separate within-patient from overall variability, but also because poor repeatability may highlight the need to re-examine the various procedures involved in gathering the data. 28 In this era of multi-gas monitoring techniques and impending automated administration of volatile anaesthetics, there is still a definite role for well validated models of human physiology and pharma cology. The results for overall variability show that a dosing regimen based on our model is a useful starting strategy for administering closed-circuit inhalation anaesthesia; the results for within-patient variability suggest that a patient may benefit from using a starting regimen corrected from the findings obtained during a former anaesthetic.
Appendix 1
A concise non-mathematical account o f the model is presented here. A comprehensive quantification and mathematical formulation have been presented elsewhere.1 Our physiological model depicts the body and closed anaesthetic circuit as a system of 14 compartments (fig. 4) . A liquid anaesthetic agent injected directly into the closed system is assumed to mix uniformly after vaporization with the contents of the closed breathing system. The anaesthetic agent is taken up from the alveolar space and distributed to the other tissue compartments; heart, brain, kidneys, liver (including all other well-perfused organs), muscles, connective tissue and adipose tissue. The model derives from the subject's age, sex, body weight and heights the other physiological variables, including deadspace, alveolar space, blood volume, cardiac output and tissue volumes. 
Appendix 2
Suppose we have p patients called i (t= l, 2, . . . , p) with m repeated observations on the same patient, giving a total of pm results for each of the three performance measures. If any one of these results is y^ (k~l, 2, . . . , in), then the individual mean result for patient i is:
J2i
Vi z , y tk mi The individual sd , that is a measure of the dispersion of the m repeated observations on the same subject, is given as:
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The grand mean for the sample population is: 
